David R. Walt, Director at Cerulean Pharma Inc. (CERU), bought 8,563 shares at $2.31 ($20K) on 2016-02-04, disclosed to the SEC on 2016-02-08.
Scheduled purchase ($20k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.31 | 4,063 | $9K | 47.7% |
| 2 | $2.29 | 4,500 | $10K | 52.3% |
| Total | $2.30 avg | 8,563 | $20K | 100% |
| Filing → |
| QTRX | BUY | 2024-09-17 | $625K | — | Filing → |
| QTRX | BUY | 2022-08-10 | $2.6M | — | Filing → |
| QTRX | BUY | 2020-03-17 | $1.8M | — | Filing → |